Today: 4 February 2026
Subscribe
Browse Category

Investment News News 15 January 2026

Fresnillo stock slides nearly 4% as silver cools — Citi target and Probe deal steps in focus

Fresnillo stock slides nearly 4% as silver cools — Citi target and Probe deal steps in focus

London, Jan 15, 2026, 09:12 GMT — Regular session Fresnillo (FRES.L) shares dipped on Thursday as silver prices slipped from their record highs, weighing on the London-listed miner. By 09:12 GMT, the stock had dropped 3.8% to 3,624 pence, down from Wednesday’s close of 3,766 pence. (Investing) Bullion pulled back after a strong rally. Spot silver dropped 3.4% to $89.63…
15 January 2026
·····
GSK stock rises as pipeline talk hits JPM conference, with Feb. 4 earnings in focus

GSK stock rises as pipeline talk hits JPM conference, with Feb. 4 earnings in focus

New York, January 15, 2026, 02:30 EST — The market has closed. GSK plc’s shares traded in the U.S. climbed 1.8% on Wednesday, closing at $50.79. The stock remains in the spotlight heading into Thursday’s session. U.S. markets were closed overnight, leaving investors to watch for follow-through in premarket trading and in London after a week packed with conference headlines…
15 January 2026
······
Anglo American stock: Norges Bank tops 3% stake as copper surge keeps miners in play

Anglo American stock: Norges Bank tops 3% stake as copper surge keeps miners in play

London, Jan 15, 2026, 07:01 GMT — Premarket Ahead of Thursday’s London open, Anglo American stock (AAL.L) caught attention after a regulatory filing revealed Norges Bank boosted its stake above the 3% reporting threshold. The bank now holds 3.00352% of voting rights, or 35,383,000 shares, up from 2.99573%. According to the filing, the threshold was crossed on Jan. 9. (TradingView)…
15 January 2026
····
Rivian stock tumbles on UBS sell call — what to watch before Thursday’s open

Rivian stock tumbles on UBS sell call — what to watch before Thursday’s open

New York, January 14, 2026, 21:33 (EST) — Market closed. Rivian Automotive (RIVN.O) shares dropped 7.2% to $17.50 on Wednesday following a downgrade from UBS, which cut the EV maker to Sell from Neutral. Despite raising its price target to $15, UBS warned the stock remains “prone to sentiment swings.” (TipRanks) With U.S. markets closed, the downgrade hits as a…
15 January 2026
·····
Texas Instruments stock beats a weak market; Jan. 27 earnings now in focus

Texas Instruments stock beats a weak market; Jan. 27 earnings now in focus

New York, January 14, 2026, 21:19 EST — Market closed. Texas Instruments (TXN.O) shares rose 2.6% on Wednesday to close at $193.45, bucking a broader market slide after two straight losing sessions. The move lands with the analog chipmaker heading into a key checkpoint later this month. Texas Instruments said it will webcast its fourth-quarter and full-year 2025 earnings conference…
15 January 2026
·····
SLB stock closes at fresh 52-week high as Venezuela oil push keeps traders circling

SLB stock closes at fresh 52-week high as Venezuela oil push keeps traders circling

New York, Jan 14, 2026, 20:48 EST — Market closed. Shares of SLB Ltd (NYSE:SLB) jumped 2.33%, closing Wednesday at $46.97. It marked their second day up and hit a fresh 52-week high, with trading volume well above the 50-day average. Baker Hughes climbed 2.06%, Halliburton gained 1.32%, while the S&P 500 slipped 0.53%. (MarketWatch) The recent developments hold weight…
15 January 2026
····
Amphenol stock slips after the bell as UBS lifts target ahead of Jan. 28 earnings

Amphenol stock slips after the bell as UBS lifts target ahead of Jan. 28 earnings

New York, Jan 14, 2026, 20:42 EST — Market closed Amphenol Corp shares were last down 1.4% at $146.75 in late trading after U.S. markets closed, even as fresh analyst notes pushed up price targets ahead of the company’s next earnings report. UBS analyst Joseph Spak kept a Buy rating and raised his price target on Amphenol to $174 from…
15 January 2026
······
Merck stock rises as $70 billion growth target sharpens focus ahead of Feb. 3 earnings

Merck stock rises as $70 billion growth target sharpens focus ahead of Feb. 3 earnings

New York, Jan 14, 2026, 20:15 EST — Market closed Merck & Co (Merck & Company, Inc., MRK) shares closed Wednesday up 2.54% at $111.01, rebounding from a short dip and holding close to recent peaks ahead of Thursday’s trading. This move is crucial as Merck works to reshape the conversation about what will follow Keytruda, its top-selling drug, once…
15 January 2026
·····
Lumentum stock sinks 8% after tech-led slide — what traders watch next

Lumentum stock sinks 8% after tech-led slide — what traders watch next

New York, Jan 14, 2026, 19:29 EST — After-hours Lumentum Holdings’ stock plunged 8.2% on Wednesday, closing at $331.62 before nudging higher to around $332 in after-hours trading. (MarketWatch) This move is significant as Lumentum has ranked among the most crowded “AI infrastructure” plays. Yet the tape has turned against pricey winners. With earnings season kicking off, investors are faster…
15 January 2026
·····
Accenture stock jumps after hours as Infosys outlook lifts IT services mood

Accenture stock jumps after hours as Infosys outlook lifts IT services mood

New York, Jan 14, 2026, 18:41 EST — After-hours Accenture plc shares jumped 4.3% in after-hours trading Wednesday, closing at $288.54. This shift carries weight as IT services stocks have been jolted by doubts over whether key clients are putting off “discretionary” projects — the kind that get shelved when budgets shrink. A clear signal from a leading outsourcer can…
15 January 2026
······
Eli Lilly stock dips after hours as FDA seeks label change for Zepbound, traders eye obesity pill push

Eli Lilly stock dips after hours as FDA seeks label change for Zepbound, traders eye obesity pill push

NEW YORK, Jan 14, 2026, 6:33 PM EST — After-hours Eli Lilly shares slipped in after-hours trading Wednesday, as investors digested a U.S. regulatory update on weight-loss drug labels alongside new marketing chatter about the company’s upcoming obesity treatment. The FDA’s move to remove suicide warnings from GLP-1 weight-loss drugs comes at a tricky time for the sector. Demand is…
15 January 2026
····
1 … 62 63 64 65 66 … 204

Stock Market Today

  • Becton Dickinson (BDX) Valuation Review Amid Mixed Share Price Performance
    February 4, 2026, 7:55 AM EST. Becton Dickinson's (BDX) share price shows short-term gains with a 2.27% rise in one day and 17.07% over 90 days, yet its long-term returns remain negative over one, three, and five years. The stock closed near $206.50, close to a fair value estimate of $204.83, implying a slight overvaluation of 0.8%. The company's upcoming separation of its Biosciences and Diagnostic Solutions segment aims to focus BDX as a pure-play medical technology firm, expected to boost cash flow and margins. However, risks such as trade tensions and execution challenges persist. Notably, a discounted cash flow (DCF) model values BDX significantly higher at approximately $330.31, suggesting a potentially undervalued opportunity depending on growth and risk assessments.
Go toTop